H.R. 19 · 117th Congress · House

Lower Costs, More Cures Act of 2021

Active· Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Introduced
Apr 21, 21
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending
H.R. 3682
117th Congress
Improving Transparency to Lower Drug Costs Act of 2021

Referred to the Subcommittee on Health.

Related bill
by CRS
Jun 2, 2021
H.R. 3682
117th Congress
Improving Transparency to Lower Drug Costs Act of 2021

Referred to the Subcommittee on Health.

Related bill
by CRS
Jun 2, 2021
S. 164
117th Congress
Related bill
by CRS
Apr 23, 2021
S. 164
117th Congress
Related bill
by CRS
Apr 23, 2021
S. 898
117th Congress
Fair Accountability and Innovative Research Drug Pricing Act of 2021

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Related bill
by CRS
Mar 23, 2021
S. 898
117th Congress
Fair Accountability and Innovative Research Drug Pricing Act of 2021

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Related bill
by CRS
Mar 23, 2021
H.R. 1873
117th Congress
Advancing Education on Biosimilars Act of 2021

Referred to the Subcommittee on Health.

Related bill
by CRS
Mar 16, 2021
H.R. 1873
117th Congress
Advancing Education on Biosimilars Act of 2021

Referred to the Subcommittee on Health.

Related bill
by CRS
Mar 16, 2021
H.R. 1857
117th Congress
Related bill
by CRS
Mar 12, 2021
H.R. 1857
117th Congress
Related bill
by CRS
Mar 12, 2021
H.R. 153
117th Congress
Protecting Consumer Access to Generic Drugs Act of 2021

Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.

Related bill
by CRS
Mar 4, 2021
H.R. 153
117th Congress
Protecting Consumer Access to Generic Drugs Act of 2021

Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.

Related bill
by CRS
Mar 4, 2021